Log in to save to my catalogue

Nuclear Uptake and Dosimetry of ^sup 64^Cu-Labeled Chelator-Somatostatin Conjugates in an SSTr2-Tran...

Nuclear Uptake and Dosimetry of ^sup 64^Cu-Labeled Chelator-Somatostatin Conjugates in an SSTr2-Tran...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_219161035

Nuclear Uptake and Dosimetry of ^sup 64^Cu-Labeled Chelator-Somatostatin Conjugates in an SSTr2-Transfected Human Tumor Cell Line

About this item

Full title

Nuclear Uptake and Dosimetry of ^sup 64^Cu-Labeled Chelator-Somatostatin Conjugates in an SSTr2-Transfected Human Tumor Cell Line

Publisher

New York: Society of Nuclear Medicine

Journal title

The Journal of nuclear medicine (1978), 2007-08, Vol.48 (8), p.1390

Language

English

Formats

Publication information

Publisher

New York: Society of Nuclear Medicine

More information

Scope and Contents

Contents

^sup 64^Cu radiopharmaceuticals have shown tumor growth inhibition in tumor-bearing animal models with a relatively low radiation dose that may be related to nuclear localization of the ^sup 64^Cu in tumor cells. Here we address whether the nuclear localization of ^sup 64^Cu from a ^sup 64^Cu-labeled chelator-somatostatin conjugate is related to th...

Alternative Titles

Full title

Nuclear Uptake and Dosimetry of ^sup 64^Cu-Labeled Chelator-Somatostatin Conjugates in an SSTr2-Transfected Human Tumor Cell Line

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_219161035

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_219161035

Other Identifiers

ISSN

0161-5505

E-ISSN

1535-5667

How to access this item